Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 5, 2007, Pages 729-734

  Withrow, Kirk P ^a   Gleysteen, John P ^a   Safavy, Ahmad ^b   Skipper, Joni ^a   Desmond, Renee A ^c   Zinn, Kurt ^c   Rosenthal, Eben L ^a  

^a Kentucky   (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CETUXIMAB INDOCYANINE GREEN CONJUGATE; INDOCYANINE GREEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG CONJUGATION; FLUORESCENCE; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MALE; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; STEREOMICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; INDOCYANINE GREEN; MALE; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 35448930723     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.06.736     Document Type: Article

References (13)

1. Ravasz L.A., Slootweg P.J., Hordijk G.J., et al. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg 19 (1991) 314-318
2. O'Brien C.J., McNeil E.B., McMahon J.D., et al. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 24 (2002) 417-422
3. Bernier J., Vermorken J.B., and Koch W.M. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol 24 (2006) 2629-2635
4. Rosenthal E.L., Kulbersh B.D., Duncan R.D., et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope 116 (2006) 1636-1641
5. Stummer W., Pichlmeier U., Meinel T., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7 (2006) 392-401
6. Tanaka E., Choi H.S., Fujii H., et al. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mappingl. Ann Surg Oncol 13 (2006) 1671-1681
7. Parungo C.P., Ohnishi S., De Grand A.M., et al. In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Ann Surg Oncol 11 (2004) 1085-1092
8. Parungo C.P., Ohnishi S., Kim S.W., et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129 (2005) 844-850
9. Muguruma N., Ito S., Hayashi S., et al. Antibodies labeled with fluorescence-agent excitable by infrared rays. J Gastroenterol 33 (1998) 467-471
10. Katayama A., Bandoh N., Kishibe K., et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10 (2004) 634-640
11. Ang K.K., Andratschke N.H., and Milas L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58 (2004) 959-965
12. Ito S., Muguruma N., Kusaka Y., et al. Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. Endoscopy 33 (2001) 849-853
13. Inayama K., Ito S., Muguruma N., et al. Basic study of an agent for reinforcement of near-infrared fluorescence on tumor tissue. Dig Liver Dis 35 (2003) 88-93